GLSI — Greenwich Lifesciences Share News
0.000.00%
Last trade - 00:00- $235.29m
- $226.42m
Greenwich Lifesciences Inc expected to post a loss of 24 cents a share - Earnings Preview
Greenwich Lifesciences Inc expected to post a loss of 24 cents a share - Earnings Preview
Greenwich Lifesciences Inc reports results for the quarter ended December 31 - Earnings Summary
Greenwich Lifesciences Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Greenwich Lifesciences Provides Global Update On Flamingo-01
U.S. STOCKS ON THE MOVE-Sarepta, Amazon, Sportman's Warehouse
U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group
U.S. STOCKS ON THE MOVE-Greenwich, CoreWeave, Blackberry
Greenwich rises on immune response data from breast cancer therapy trial
Brief: Greenwich Lifesciences Announces Positive Immune Response Data From FLAMINGO-01 Phase III Clinical Trial
Greenwich Lifesciences Inc reports results for the quarter ended September 30 - Earnings Summary
Greenwich Lifesciences Inc expected to post a loss of 21 cents a share - Earnings Preview
Greenwich Lifesciences Inc expected to post a loss of 21 cents a share - Earnings Preview
Greenwich Lifesciences Inc expected to post a loss of 21 cents a share - Earnings Preview
Greenwich Lifesciences Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Greenwich Lifesciences Files For Mixed Shelf Offering Of Upto $275 Million - SEC Filing
Greenwich Lifesciences Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Greenwich Lifesciences Announces $2.5 Million Private Placement
Greenwich Lifesciences Inc reports results for the quarter ended in March - Earnings Summary